Healthcare provider profile · identity verified

Christopher J Murray, D.O.

General Practice · ALMA, MI · NPI 1821024787

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	587	155
Levothyroxine Sodium	Levothyroxine Sodium	502	119
Amlodipine Besylate	Amlodipine Besylate	432	121
Lisinopril	Lisinopril	382	107
Metformin Hcl	Metformin Hcl	379	107
Omeprazole	Omeprazole	372	99
Simvastatin	Simvastatin	335	95
Gabapentin	Gabapentin	311	68
Losartan Potassium	Losartan Potassium	306	87
Metoprolol Tartrate	Metoprolol Tartrate	232	61
Hydrochlorothiazide	Hydrochlorothiazide	206	63
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	198	31
Metoprolol Succinate	Metoprolol Succinate	167	48
Pantoprazole Sodium	Pantoprazole Sodium	165	40
Potassium Chloride	Potassium Chloride	151	41
Rosuvastatin Calcium	Rosuvastatin Calcium	144	42
Fluoxetine Hcl	Fluoxetine Hcl	139	32
Pravastatin Sodium	Pravastatin Sodium	135	36
Tamsulosin Hcl	Tamsulosin Hcl	134	41
Clopidogrel	Clopidogrel Bisulfate	119	29
Furosemide	Furosemide	106	32
Prednisone	Prednisone	106	59
Tramadol Hcl	Tramadol Hcl	106	19
Sertraline Hcl	Sertraline Hcl	103	29
Trulicity	Dulaglutide	100	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	97	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	96	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	93	24
Atenolol	Atenolol	88	24
Fluticasone Propionate	Fluticasone Propionate	88	28
Albuterol Sulfate Hfa	Albuterol Sulfate	86	33
Eliquis	Apixaban	85	25
Glipizide	Glipizide	84	21
Lorazepam	Lorazepam	83	20
Alprazolam	Alprazolam	72	13
Meloxicam	Meloxicam	69	25
Escitalopram Oxalate	Escitalopram Oxalate	64	15
Ozempic	Semaglutide	63	12
Finasteride	Finasteride	62	18
Pregabalin	Pregabalin	62	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	19
Allopurinol	Allopurinol	58	17
Duloxetine Hcl	Duloxetine Hcl	55	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	54	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	54	15
Trazodone Hcl	Trazodone Hcl	53	18
Famotidine	Famotidine	52	13
Warfarin Sodium	Warfarin Sodium	51	17
Carvedilol	Carvedilol	50	17
Clonidine Hcl	Clonidine Hcl	49	suppressed
Januvia	Sitagliptin Phosphate	47	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	13
Spironolactone	Spironolactone	46	16
Paroxetine Hcl	Paroxetine Hcl	45	11
Alendronate Sodium	Alendronate Sodium	44	15
Morphine Sulfate Er	Morphine Sulfate	44	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	44	11
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	43	suppressed
Glipizide Er	Glipizide	43	14
Ibuprofen	Ibuprofen	42	suppressed
Clonazepam	Clonazepam	41	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	41	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	41	20
Glimepiride	Glimepiride	39	suppressed
Bumetanide	Bumetanide	38	suppressed
Cephalexin	Cephalexin	38	29
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Buspirone Hcl	Buspirone Hcl	37	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	suppressed
Methadone Hcl	Methadone Hcl	36	suppressed
Lovastatin	Lovastatin	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Estradiol	Estradiol	31	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Gemfibrozil	Gemfibrozil	30	suppressed
Jardiance	Empagliflozin	30	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	29	15
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Novolog Flexpen	Insulin Aspart	28	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	26	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	18
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Metformin Hcl Er	Metformin Hcl	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Amoxicillin	Amoxicillin	21	suppressed
Azithromycin	Azithromycin	21	17
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	11
Diazepam	Diazepam	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Naproxen	Naproxen	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Rizatriptan	Rizatriptan Benzoate	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Fluconazole	Fluconazole	18	11
Jantoven	Warfarin Sodium	18	suppressed
Tizanidine Hcl	Tizanidine Hcl	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	12
Meclizine Hcl	Meclizine Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	15
Promethazine Hcl	Promethazine Hcl	17	suppressed
Topiramate	Topiramate	17	suppressed
Diltiazem Hcl	Diltiazem Hcl	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	16	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	15	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Mirtazapine	Mirtazapine	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	12
Ibu	Ibuprofen	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Baclofen	Baclofen	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Nitroglycerin	Nitroglycerin	13	11
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Nystatin	Nystatin	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Tramadol Hcl Er	Tramadol Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	12	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Ramipril	Ramipril	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error